Table 2.
Protein |
Function |
Length[b] |
Name |
Type |
Length[c] |
Kd [μM][d] |
Ref. |
---|---|---|---|---|---|---|---|
ARQ23 |
Androgen receptor |
46 |
QF2D‐2 |
Linear |
16 |
11 |
|
Annexin A1 NTD |
Surface marker in malignant tumor vasculature |
16 |
D‐TIT7 |
Linear |
7 |
8.5 x10−3 |
|
Tau PHF6* |
Microtubule‐associated protein |
6 |
MMD3 |
Linear |
12 |
[e] |
|
MMD3rev |
Linear |
12 |
[e] |
||||
Tau PHF6 |
p‐NH |
Linear |
12 |
[e] |
|||
TD28 |
Linear |
12 |
[e] |
||||
Immunoglobulin variable domain of TIGIT |
Immune checkpoint |
119 |
D‐TBP‐3 |
Linear |
12 |
5.6 |
|
Epidermal growth factor |
Mitogenic factor |
53 |
D‐PI_4 |
Linear |
12 |
54 |
|
Fibroblast growth factor‐inducible 14 CRD |
TWEAK (tumor necrosis factor‐like weak inducer of apoptosis) receptor |
43 |
D‐FNB |
Linear |
12 |
0.28 |
|
Aβ‐1‐42 |
Monomeric precursor of AB oligomers and fibrils |
42 |
Mosd1 |
Linear |
12 |
[e] |
|
Immunoglobulin variable domain of PD‐L1 |
Programmed cell death protein 1 |
124 |
D‐PPA‐1 |
Linear |
12 |
0.51 |
|
VEGF‐A |
Vascular endothelial growth factor |
102 |
RFX‐V1a2a |
Bivalent scaffold |
53+58 |
8 x10−4 |
|
RFX001 |
GB1 scaffold |
56 |
8.5 x10−2 |
||||
gp41N‐trimer pocket mimic |
HIV envelope protein ectodomain |
42 |
PIE12‐trimer |
Flanking disulfide cyclic |
8 [f] |
[e] |
|
MDM2 |
Oncogenic E3 ubiquitin ligase |
85 |
D‐PMIα |
Linear |
12 |
5.3 x 10−2 |
[a] Most potent binder from phage panning experiments presented. [b] Total amino acid length of synthetic protein enantiomer target. [c] Amino acid length of peptide binder identified through phage display. [d] Reported dissociation constant of D‐peptide binder to native L‐target used in phage display. [e] Kd not reported. [f] Length of original, un‐crosslinked peptide identified through phage display.